The anti-tumorigenic cytokine TNF-alpha can inhibit GSK-3beta activity by stimulating Akt to phosphorylate GSK-3beta at S9 in renal carcinoma cells (RCC). This evidence concerns the gene GSK3B and renal cell carcinoma.